GCA
RGEN icon

Greenwood Capital Associates’s Repligen RGEN Stock Holding History

Greenwood Capital Associates’s Portfolio RGEN Stock Details RGEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-3,490
Closed -$924K – 231
2021
Q4 		$924K Buy
3,490
+60
+2% +$16.2K 0.13% 132
2021
Q3 		$991K Buy
3,430
+107
+3% +$27.4K 0.15% 109
2021
Q2 		$663K Buy
3,323
+86
+3% +$16.7K 0.1% 158
2021
Q1 		$629K Buy
3,237
+229
+8% +$47K 0.1% 158
2020
Q4 		$576K Buy
3,008
+524
+21% +$95.3K 0.1% 153
2020
Q3 		$366K Buy
2,484
+422
+20% +$60.3K 0.07% 153
2020
Q2 		$255K Sell
2,062
-584
-22% -$68.7K 0.06% 157
2020
Q1 		$255K Sell
2,646
-141
-5% -$13.6K 0.07% 120
2019
Q4 		$258K Buy
+2,787
New +$234K 0.05% 165

Other funds holding RGEN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return

Greenwood Capital Associates's RGEN Position: Q1 2022 in Review

Greenwood Capital Associates sold out of Repligen (RGEN) in Q1 2022, closing a stake of 3,490 shares — an estimated $924K sold.

Greenwood Capital Associates first reported a position in RGEN in Q4 2019 and held it in 9 quarters. The position peaked at $991K in Q3 2021. 450 funds tracked by Wall St. Rank hold RGEN as of Q1 2022.

  • Greenwood Capital Associates reported no remaining Repligen position as of Q1 2022 after selling out during the quarter.
  • Greenwood Capital Associates sold 3,490 Repligen shares in Q1 2022, an estimated $924K.
  • Greenwood Capital Associates first reported a position in Repligen in Q4 2019 and held it in 9 quarters.
  • Greenwood Capital Associates's Repligen position peaked at $991K in Q3 2021.
  • 450 funds tracked by Wall St. Rank held Repligen as of Q1 2022.

Based on Greenwood Capital Associates's 13F filing for Q1 2022, filed 10 May 2022.